Previous Article | Next Article 
Journal of Virology, January 2000, p. 428-435, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Development of Human T-Cell Leukemia Virus Type 1-Transformed
Tumors in Rats following Suppression of T-Cell Immunity by CD80 and
CD86 Blockade
Shino
Hanabuchi,1
Takashi
Ohashi,1
Yoshihiro
Koya,1
Hirotomo
Kato,1,2
Fumiyo
Takemura,1,3
Katsuiku
Hirokawa,4
Takashi
Yoshiki,5
Hideo
Yagita,3,6
Ko
Okumura,3,6 and
Mari
Kannagi1,3,*
Departments of
Immunotherapeutics1 and Pathology and
Immunology,4 Tokyo Medical and Dental
University, Medical Research Division, Department of Veterinary
Internal Medicine, Faculty of Agriculture, University of
Tokyo,2 and Department of Immunology,
Juntendo University School of Medicine,6 Tokyo
113, CREST, Japan Science and Technology Corporation, Saitama
332,3 and Department of Pathology,
Hokkaido University School of Medicine, Sapporo
060,5 Japan
Received 14 April 1999/Accepted 21 September 1999
Host immunity influences clinical manifestations of human T-cell
leukemia virus type 1 (HTLV-1) infection. In this study, we
demonstrated that HTLV-1-transformed tumors could develop in immunocompetent rats by blocking a costimulatory signal for T-cell immune responses. Four-week-old WKA/HKm rats were treated with monoclonal antibodies (MAbs) to CD80 and CD86 and subcutaneously inoculated with syngeneic HTLV-1-infected TARS-1 cells. During MAb
treatment for 14 days, TARS-1 inoculation resulted in the development
of solid tumors at the site of inoculation, which metastasized to the
lungs. In contrast, rats not treated with MAbs promptly rejected tumor
cells. Splenic T cells from MAb-treated rats indicated impairment of
proliferative and cytotoxic T-lymphocyte responses against TARS-1 in
vitro compared to untreated rats. However, tumors grown in MAb-treated
rats regressed following withdrawal of MAb therapy. Recovery of
TARS-1-specific T-cell immune responses was associated with tumor
regression in these rats. Our results suggest that HTLV-1-specific
cell-mediated immunity plays a critical role in immunosurveillance
against HTLV-1-transformed tumor development in vivo.
*
Corresponding author. Mailing address: Department of
Immunotherapeutics, Tokyo Medical and Dental University, Medical
Research Division, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113, Japan. Phone: 81 (3) 5803-5798. Fax: 81 (3) 5803-0235. E-mail:
kann.impt{at}med.tmd.ac.jp.
Journal of Virology, January 2000, p. 428-435, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nomura, M., Ohashi, T., Nishikawa, K., Nishitsuji, H., Kurihara, K., Hasegawa, A., Furuta, R. A., Fujisawa, J.-i., Tanaka, Y., Hanabuchi, S., Harashima, N., Masuda, T., Kannagi, M.
(2004). Repression of Tax Expression Is Associated both with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Killing by Tax-Specific Cytotoxic T Lymphocytes and with Impaired Tumorigenicity in a Rat Model. J. Virol.
78: 3827-3836
[Abstract]
[Full Text]
-
Harashima, N., Kurihara, K., Utsunomiya, A., Tanosaki, R., Hanabuchi, S., Masuda, M., Ohashi, T., Fukui, F., Hasegawa, A., Masuda, T., Takaue, Y., Okamura, J., Kannagi, M.
(2004). Graft-versus-Tax Response in Adult T-Cell Leukemia Patients after Hematopoietic Stem Cell Transplantation. Cancer Res.
64: 391-399
[Abstract]
[Full Text]
-
Hasegawa, A., Ohashi, T., Hanabuchi, S., Kato, H., Takemura, F., Masuda, T., Kannagi, M.
(2003). Expansion of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Reservoir in Orally Infected Rats: Inverse Correlation with HTLV-1-Specific Cellular Immune Response. J. Virol.
77: 2956-2963
[Abstract]
[Full Text]
-
Ohashi, T., Hanabuchi, S., Suzuki, R., Kato, H., Masuda, T., Kannagi, M.
(2002). Correlation of Major Histocompatibility Complex Class I Downregulation with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Cytotoxic T-Lymphocyte Killing in a Rat Model. J. Virol.
76: 7010-7019
[Abstract]
[Full Text]
-
Hanabuchi, S., Ohashi, T., Koya, Y., Kato, H., Hasegawa, A., Takemura, F., Masuda, T., Kannagi, M.
(2001). Regression of Human T-cell Leukemia Virus Type I (HTLV-I)-Associated Lymphomas in a Rat Model: Peptide-Induced T-Cell Immunity. JNCI J Natl Cancer Inst
93: 1775-1783
[Abstract]
[Full Text]
-
Mortreux, F., Leclercq, I., Gabet, A.-S., Leroy, A., Westhof, E., Gessain, A., Wain-Hobson, S., Wattel, E.
(2001). Somatic Mutation in Human T-Cell Leukemia Virus Type 1 Provirus and Flanking Cellular Sequences During Clonal Expansion In Vivo. JNCI J Natl Cancer Inst
93: 367-377
[Abstract]
[Full Text]
-
Mortreux, F., Kazanji, M., Gabet, A.-S., de Thoisy, B., Wattel, E.
(2001). Two-Step Nature of Human T-Cell Leukemia Virus Type 1 Replication in Experimentally Infected Squirrel Monkeys (Saimiri sciureus). J. Virol.
75: 1083-1089
[Abstract]
[Full Text]
-
Ohashi, T., Hanabuchi, S., Kato, H., Tateno, H., Takemura, F., Tsukahara, T., Koya, Y., Hasegawa, A., Masuda, T., Kannagi, M.
(2000). Prevention of Adult T-Cell Leukemia-Like Lymphoproliferative Disease in Rats by Adoptively Transferred T Cells from a Donor Immunized with Human T-Cell Leukemia Virus Type 1 Tax-Coding DNA Vaccine. J. Virol.
74: 9610-9616
[Abstract]
[Full Text]